Legal status · United States
Is Everolimus legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Yes. Everolimus is an approved medicine in the United States, classified as "FDA-approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 3 human studies are cited on its profile.
Everolimus in the United States at a glance
| Classification | FDA-approved, prescription only |
|---|---|
| Note | Approved for oncology indications and transplant rejection prophylaxis. Immune-ageing and longevity uses are investigational and off-label. |
| FDA approval status | FDA-approved as Afinitor for several cancers and as Zortress for prophylaxis of organ rejection. Not approved for any ageing or immune-ageing indication. |
| Human studies cited | 3 of 3 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Everolimus profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
FDA has approved Everolimus for at least one labeled indication, so a pharmaceutical-grade product exists in the United States and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Everolimus is
The rapamycin analogue that produced the first credible human geroscience result: improved influenza vaccine response in older adults in a randomised trial.
Everolimus matters to this site for a reason unrelated to its approved uses. It is an approved cancer and transplant drug, and it was also the molecule used for the first randomised trial that took the mTOR longevity hypothesis into humans and got a positive answer.
Mechanism: A rapamycin analogue, or rapalog, that binds FKBP12 and inhibits mechanistic target of rapamycin complex 1. mTORC1 is the central nutrient and growth-factor sensor: when it is active, cells build protein and suppress autophagy, and when it is inhibited, autophagy and stress resistance increase.
Regulatory history: FDA-approved as Afinitor for several cancers and as Zortress for prophylaxis of organ rejection. Not approved for any ageing or immune-ageing indication.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Everolimus at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Everolimus in other countries
Frequently asked questions
Is Everolimus legal in the United States?
Yes. Everolimus is an approved medicine in the United States, classified as "FDA-approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 3 human studies are cited on its profile. Note: Approved for oncology indications and transplant rejection prophylaxis. Immune-ageing and longevity uses are investigational and off-label.
Can I buy Everolimus in the United States?
Only with a prescription. Everolimus is classified as "FDA-approved, prescription only" in the United States, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection. Note: Approved for oncology indications and transplant rejection prophylaxis. Immune-ageing and longevity uses are investigational and off-label.
Is Everolimus FDA approved?
Yes. FDA status: FDA-approved as Afinitor for several cancers and as Zortress for prophylaxis of organ rejection. Not approved for any ageing or immune-ageing indication.. Current US classification: "FDA-approved, prescription only". On the evidence, 3 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Everolimus live on its compound profile.
Everolimus profileThis page is general information about the regulatory status of Everolimus in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.